文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

关于 COVID-19 轻症和重症患者症状的影响因素及分类研究。

Research on Influencing Factors and Classification of Patients With Mild and Severe COVID-19 Symptoms.

机构信息

College of Mathematics and Statistics & FJKLMAA, Fujian Normal University, Fuzhou, China.

Pulmonary and Critical Care Medicine, The Third People's Hospital of Dongguan City, Dongguan, China.

出版信息

Front Cell Infect Microbiol. 2021 Aug 18;11:670823. doi: 10.3389/fcimb.2021.670823. eCollection 2021.


DOI:10.3389/fcimb.2021.670823
PMID:34490135
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8418155/
Abstract

OBJECTIVE: To analyze the epidemiological history, clinical symptoms, laboratory testing parameters of patients with mild and severe COVID-19 infection, and provide a reference for timely judgment of changes in the patients' conditions and the formulation of epidemic prevention and control strategies. METHODS: A retrospective study was conducted in this research, a total of 90 patients with COVID-19 infection who received treatment from January 21 to March 31, 2020 in the Ninth People's Hospital of Dongguan City were selected as study subject. We analyzed the clinical characteristics of laboratory-confirmed patients with COVID-19, used the oversampling method (SMOTE) to solve the imbalance of categories, and established Lasso-logistic regression and random forest models. RESULTS: Among the 90 confirmed COVID-19 cases, 79 were mild and 11 were severe. The average age of the patients was 36.1 years old, including 49 males and 41 females. The average age of severe patients is significantly older than that of mild patients (53.2 years old 33.7 years old). The average time from illness onset to hospital admission was 4.1 days and the average actual hospital stay was 18.7 days, both of these time actors were longer for severe patients than for mild patients. Forty-eight of the 90 patients (53.3%) had family cluster infections, which was similar among mild and severe patients. Comorbidities of underlying diseases were more common in severe patients, including hypertension, diabetes and other diseases. The most common symptom was cough [45 (50%)], followed by fever [43 (47.8%)], headache [7 (7.8%)], vomiting [3 (3.3%)], diarrhea [3 (3.3%)], and dyspnea [1 (1.1%)]. The laboratory findings of patients also included leukopenia [13(14.4%)] and lymphopenia (17.8%). Severe patients had a low level of creatine kinase (median 40.9) and a high level of D-dimer. The median NLR of severe patients was 2.82, which was higher than that of mild patients. Logistic regression showed that age, phosphocreatine kinase, procalcitonin, the lymphocyte count of the patient on admission, cough, fatigue, and pharynx dryness were independent predictors of COVID-19 severity. The classification of random forest was predicted and the importance of each variable was displayed. The variable importance of random forest indicates that age, D-dimer, NLR (neutrophil to lymphocyte ratio) and other top-ranked variables are risk factors. CONCLUSION: The clinical symptoms of COVID-19 patients are non-specific and complicated. Age and the time from onset to admission are important factors that determine the severity of the patient's condition. Patients with mild illness should be closely monitored to identify those who may become severe. Variables such as age and creatine phosphate kinase selected by logistic regression can be used as important indicators to assess the disease severity of COVID-19 patients. The importance of variables in the random forest further complements the variable feature information.

摘要

目的:分析轻症和重症 COVID-19 感染患者的流行病学史、临床症状、实验室检测参数,为及时判断患者病情变化和制定防控策略提供参考。

方法:本研究采用回顾性研究方法,选取 2020 年 1 月 21 日至 3 月 31 日在东莞市第九人民医院接受治疗的 90 例 COVID-19 感染患者作为研究对象。我们分析了实验室确诊 COVID-19 患者的临床特征,使用过采样方法(SMOTE)解决类别不平衡问题,并建立了 Lasso-逻辑回归和随机森林模型。

结果:在 90 例确诊 COVID-19 病例中,79 例为轻症,11 例为重症。患者平均年龄为 36.1 岁,包括 49 名男性和 41 名女性。重症患者的平均年龄明显大于轻症患者(53.2 岁比 33.7 岁)。从发病到住院的平均时间为 4.1 天,实际住院平均时间为 18.7 天,这两个时间参数均长于轻症患者。90 例患者中有 48 例(53.3%)有家庭聚集性感染,轻症和重症患者之间相似。重症患者合并基础疾病的并发症更为常见,包括高血压、糖尿病等疾病。最常见的症状是咳嗽[45(50%)],其次是发热[43(47.8%)]、头痛[7(7.8%)]、呕吐[3(3.3%)]、腹泻[3(3.3%)]和呼吸困难[1(1.1%)]。患者的实验室检查还包括白细胞减少症[13(14.4%)]和淋巴细胞减少症(17.8%)。重症患者肌酸激酶水平较低(中位数 40.9),D-二聚体水平较高。重症患者的 NLR 中位数为 2.82,高于轻症患者。逻辑回归显示,年龄、肌酸激酶、降钙素原、患者入院时的淋巴细胞计数、咳嗽、乏力、咽干是 COVID-19 严重程度的独立预测因子。随机森林的分类预测显示了每个变量的重要性。随机森林的变量重要性表明,年龄、D-二聚体、NLR(中性粒细胞与淋巴细胞比值)等排名靠前的变量是危险因素。

结论:COVID-19 患者的临床症状是非特异性和复杂的。年龄和发病到入院的时间是决定患者病情严重程度的重要因素。应密切监测轻症患者,以识别可能转为重症的患者。逻辑回归选择的年龄和磷酸肌酸激酶等变量可作为评估 COVID-19 患者疾病严重程度的重要指标。随机森林中变量的重要性进一步补充了变量特征信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d44/8418155/c52249d2eb1b/fcimb-11-670823-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d44/8418155/85ebdfa6c0b6/fcimb-11-670823-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d44/8418155/90fae04991e5/fcimb-11-670823-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d44/8418155/98fab3c0b259/fcimb-11-670823-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d44/8418155/d52a74b6b2eb/fcimb-11-670823-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d44/8418155/cb0eabf2f90a/fcimb-11-670823-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d44/8418155/c52249d2eb1b/fcimb-11-670823-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d44/8418155/85ebdfa6c0b6/fcimb-11-670823-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d44/8418155/90fae04991e5/fcimb-11-670823-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d44/8418155/98fab3c0b259/fcimb-11-670823-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d44/8418155/d52a74b6b2eb/fcimb-11-670823-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d44/8418155/cb0eabf2f90a/fcimb-11-670823-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d44/8418155/c52249d2eb1b/fcimb-11-670823-g006.jpg

相似文献

[1]
Research on Influencing Factors and Classification of Patients With Mild and Severe COVID-19 Symptoms.

Front Cell Infect Microbiol. 2021

[2]
Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020-5-28

[3]
Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.

BMC Infect Dis. 2021-1-25

[4]
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.

Allergy. 2020-2-27

[5]
Clinical characteristics and outcomes of 48 patients hospitalized for COVID-19 infection in Wuxi: A retrospective cohort study.

Medicine (Baltimore). 2021-2-5

[6]
Epidemiological and clinical characteristics of 1663 hospitalized patients infected with COVID-19 in Wuhan, China: a single-center experience.

J Infect Public Health. 2020-7-17

[7]
Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients.

Allergy. 2021-2

[8]
Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China.

Ther Adv Respir Dis. 2020

[9]
The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.

Thromb Res. 2020-5-6

[10]
Data from the first wave of Covid-19 from the Central Military Hospital, Prague, Czech Republic.

Epidemiol Mikrobiol Imunol. 2020

引用本文的文献

[1]
Prevalence of Hypertension and Diabetes in Severe COVID-19: A Cross-Sectional Study from Single Center, Kabul.

Infect Drug Resist. 2024-4-30

本文引用的文献

[1]
Elevated D-Dimer Levels Are Associated With Increased Risk of Mortality in Coronavirus Disease 2019: A Systematic Review and Meta-Analysis.

Cardiol Rev. 2020-7-2

[2]
The implications of silent transmission for the control of COVID-19 outbreaks.

Proc Natl Acad Sci U S A. 2020-7-6

[3]
Lymphocyte Subset Counts in COVID-19 Patients: A Meta-Analysis.

Cytometry A. 2020-7-18

[4]
Overview of lethal human coronaviruses.

Signal Transduct Target Ther. 2020-6-10

[5]
NLR: A Cost-effective Nomogram to Guide Therapeutic Interventions in COVID-19.

Immunol Invest. 2021-1

[6]
Viral and host factors related to the clinical outcome of COVID-19.

Nature. 2020-5-20

[7]
Myocardial injury and COVID-19: Possible mechanisms.

Life Sci. 2020-4-28

[8]
The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients.

Int Immunopharmacol. 2020-4-13

[9]
Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome.

Circulation. 2020-4-16

[10]
Study of cardiovascular disease prediction model based on random forest in eastern China.

Sci Rep. 2020-3-23

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索